How much does a bottle of platinib targeted drug cost?

Pralsetinib is a targeted drug mainly used to treat non-small cell lung cancer and other related cancers with positive RET gene mutations. Although Platinib is already on the market in China, it has not yet been included in the medical insurance reimbursement system, so patients can only purchase it at their own expense. Common packaging specifications include 100mg 60 capsules and 100mg 120 capsules, which are relatively expensive. According to the sales price in different regions, the price of a box of platinib is usually more than 20,000 yuan, and in some places it can even be as high as 60,000 yuan.

In comparison, the price of platinib in overseas markets is even more expensive, especially in Europe and the United States. The price of a box of 60 pills usually fluctuates between 40,000 and 100,000 yuan, which is a huge financial burden for patients. Therefore, many patients choose to purchase this drug through legal overseas drug purchasing channels. Although overseas originator drugs are expensive, patients often need to weigh whether to choose this treatment method based on their specific circumstances.

It is worth noting that generic drugs of Platinib have been launched in overseas markets, and the price is relatively affordable. Taking the generic drug Platinib produced in Laos as an example, the price of 120 tablets is about more than 3,000 yuan, which undoubtedly provides a more cost-effective option for patients who require long-term treatment. The ingredients of generic drugs are basically the same as those of original drugs, so their therapeutic effects can reach a similar level, making them the first choice for some patients.

Although generic drugs have a price advantage, patients still need to use them under the advice of their doctors and make sure to purchase them through formal channels to ensure the safety and efficacy of the drugs. Patients should pay attention to the latest policy changes for platinib, especially the progress regarding medical insurance reimbursement. Once platinib is included in medical insurance in the future, patients' treatment burden is expected to be alleviated to a certain extent.

Reference materials:https://gavreto.com/